학술논문
Efficacy and safety of celecoxib monotherapy for treatment of moderate depressive symptoms following COVID-19 infection: A randomized, double-blind, placebo-controlled trial
Document Type
Article
Author
Source
In Journal of Psychosomatic Research November 2023 174
Subject
Language
ISSN
0022-3999